Introduction
The maintenance of health and clarity of the cornea is imperative for both the protection of the inner structures of the eye and to allow light into the eye leading to visual functions. There are many situations in which the cornea can be injured or damaged by disease, which inhibit the ability of light to enter the eye and this can have a significant effect on vision. In many, although not all, of these situations the rest of the eye is unaffected and capable of processing light if it could reach the back of the eye. In these cases it may be appropriate to consider how the transparency of these tissues can be restored. One approach may be to consider how regenerative medicine and tissue engineering
Conjunctiva
The conjunctival epithelium is a stratified epithelium consisting of epithelial cells and goblet cells (Figure 1 ). The goblet cells are larger than the epithelial cells and are embedded in the stratified epithelial cell layers. The goblet cells are distributed throughout the conjunctiva with some areas having greater concentrations than others. [2] The goblet cells secrete mucins and these stabilize the tear film and help to maintain the attachment of the tears to the epithelial surface of the cornea. A healthy conjunctiva and tear film helps in maintaining the homeostasis of the ocular surface. The conjunctiva lines the eye lids and the sclera and folds into the fornices.
Tear Film
The tears are a complex fluid composed of water, salts, glucose, proteins, lipids, and mucins ( Figure 1 ). The correct composition is important to promote attachment of the tear film to the epithelium. The intact epithelium with its stable tear film provides a barrier to detrimental environmental factors including microbes and harmful chemicals.
The outermost layer of the tear film is formed of lipids. These hydrophobic and surfactant molecules, secreted by the meibomian glands near the rims of the eyelids, create a barrier at the air-liquid interface which reduces evaporation of the tear film. The liquid/mucus portion of tears contains antimicrobial proteins and stabilizing mucins. Key proteins in the tear film are albumin, lysozyme, transferrin, defensin, and immunoglobulins. The gel-forming mucin MUC5AC is secreted by the goblet cells of the conjunctiva, and along with the MUC7 secreted by the lacrimal glands helps to stabilize the tear film by increasing the viscosity. Reduced number of goblet cells in many injuries and diseases has been implicated to dry eye syndrome due to destabilization of the tear film. Portions of transmembrane mucins (MUC1, 4, 16, and 20) which have been cleaved are also found in the tear film. [3] These transmembrane mucins form part of the glycocalyx at the epithelial surface, along with the corneal epithelial cell microvilli mentioned above, which help to stabilize the film.
Trabecular Meshwork
The trabecular meshwork has a sieve-like structure that is responsible for controlling the flow rate of aqueous humor from the anterior chamber to maintain the intraocular pressure (IOP) (Figure 2) . The trabecular meshwork is composed of three structurally different filtering regions composed of connective tissue beams of lamellae and perforated sheets forming the uveal, corneoscleral (CS), and juxtacanalicular (JCT) regions. [4] There is a fourth nonfiltering region, termed the insert region, where the trabecular meshwork inserts under the periphery of the corneal endothelium and is the location of the progenitor cell niche. [5] The uveal meshwork is located closest to the anterior chamber, composed of large connective tissue beams of lamellae which form large irregular intratrabecular spaces. The CS region is composed of flatter lamellae with progressively smaller intratrabecular spaces toward the JCT. The JCT region is situated adjacent to Schlemm's canal and is composed of less porous loose connective tissue of fibrillar extracellular matrix (ECM). [4] Aqueous humor flows through the intratrabecular spaces of the highly porous uveal and CS regions, where confluent endothelial-like trabecular meshwork cells cover the lamellae beams. These cells are highly phagocytic, functioning to remove debris from the aqueous humor before it enters the less porous JCT. [6] The uveal and CS regions of the trabecular meshwork offer little resistance to aqueous humor and it is within the JCT that there is the greatest resistance to aqueous humor, which controls the intraocular pressure. The JCT undergoes mechanical stretching and distortion due to pressure changes and adjustments to the aqueous humor outflow occur in response to these sustained pressure increases.
Trabecular meshwork cells within the JCT are able to sense and respond to these changes in stretching and pressure to maintain IOP homeostasis by modulating the turnover of the ECM proteins. [7] 
Limbus
The limbus is a specialized region of the anterior segment of the eye where the cornea meets the sclera (Figure 2 ). At the outer surface it identifies the border between the corneal epithelium and the conjunctiva and at the inner surface it marks the boundary between the corneal endothelium and the trabecular meshwork. What is particularly important about the limbus is that it is where the stem cells for these tissues reside. Limbal epithelial stem cells (LESCs) reside in the basal layer and migrate to repopulate the epithelium and maintain a healthy external surface. In 2005, Funderburgh et al. identified a population of cells expressing ABCG2 and Pax6 proteins in the anterior peripheral (limbal) stroma subjacent to LESCs. [8] These cells have since been termed the corneal stromal stem cells (CSSCs). Pax6 is typically only expressed in embryonic precursors and epithelial cells but absent in adult keratocytes so expression in CSSCs is useful to distinguish this population from the remaining keratocytes in the stroma. The physical stem cell niche of the CSSCs has not been investigated to the same extent as the LESCs but it is unlikely to be coincidental that the CSSCs are found in such close proximity to the LESCs. This region of limbal stroma is populated by blood vessels as well as melanocytes which may also contribute to the CSSC niche. [9] A progenitor cell niche also resides within the posterior limbus at Schwalbe's line between the periphery of the corneal endothelium and the nonfiltering region of the trabecular meshwork. [5] Evidence suggests that these progenitor cells can differentiate into either corneal endothelial cells or trabecular meshwork cells. [5, 10, 11] Whikehart et al. demonstrated that the cells located at the peripheral corneal endothelium displayed increased cell density as well as increased telomerase activity, combined with Bromodeoxyuridine labeling within the insert region and also within the trabecular meshwork. [12] Following argon laser trabeculoplasty of ex vivo organ cultures there was an increase in cell division within cells in the nonfiltering insert region of the trabecular meshwork [13] and the cells migrated into the posterior trabecular meshwork. Isolation and amplification of progenitor cells from the trabecular meshwork using a floating sphere culture method [14] or cell sorting of a side population [15] showed the expression of stem cell characteristics and differentiation of these cells subsequently resulted in the expression of trabecular meshwork markers. The progenitor cells of the insert region offer a potential source of cells to regenerate both the corneal endothelium and the trabecular meshwork.
Corneal Damage and Repair
The ocular surface can be damaged by trauma or disease, for example, chemical burns or other disorders such as Stevens-Johnson syndrome associated with a hypersensitivity response to a medication and Sjorgren syndrome often associated with rheumatoid arthritis or mucus membrane pemphigoid which is a rare autoimmune disorder. Most are associated with damage to the epithelial surface and once severe may require corneal transplant surgery. In many cases, both the cornea and conjunctiva will be affected and therefore the tear film may also be compromised. Thus, when considering routes to reconstruct the ocular surface it is important to consider the whole surface not just the individual components. In this respect the traditional treatment for severe damage to the cornea is a corneal transplant, but one should also ensure the replacement of the conjunctival epithelium if necessary to promote the continued production of mucins to maintain a healthy tear film otherwise the corneal transplant is likely to fail.
Although corneal transplants are the primary treatment for corneal damage, there is a significant shortage of corneas available for transplantation and so there has been research for many years on alternative strategies involving tissue engineering and regenerative medicine. Most research has involved the cornea with far fewer studies being completed on conjunctival replacement strategies or on the effect of these strategies on the tear film.
Limbal Stem Cell Deficiency
A failure of the limbal tissue to function normally can lead to a painful and blinding eye condition called limbal stem cell deficiency (LSCD). Patients with LSCD may initially complain of decreased vision and photophobia and as the limbal function declines, recurrent epithelial defects and superficial vascularization, with further deterioration of vision. In severe cases, persistent epithelial defects can result in scarring, ulceration, stromal neovascularization, corneal thinning, or even perforation/ conjunctivalization of the corneal surface. LSCD is most commonly caused by mechanical microtrauma, hypoxia, inflammation, or irritation and less commonly by genetic causes, all of which can cause damage to the stem cells or surrounding microenvironment/niche. Consequently, the desquamated cells of the corneal surface cannot be replaced by proliferating basal epithelial cells migrating from the LESC niche so instead conjunctival epithelial cells aberrantly migrate to cover the surface causing corneal opacification. These patients clearly need a corneal transplant but these will fail unless the LSCD is treated first.
Holoclar
The first stem cell based medicinal product approved by the European Medicines Agency was Holoclar which is a product involving a fibrin membrane and autologous limbal stem cells (LSCs). [16] This product is approved for limbal stem cell deficiency in patients with chemical burns in one eye, so that there is the potential to take a limbal explant from the fellow eye. These cells are expanded in culture, seeded onto the fibrin membrane, and then transplanted onto the patient's eye having removed the conjunctival scar tissue. [17] This approach has been shown to promote the growth of a healthy corneal epithelium and inhibit the overgrowth of the conjunctiva. The limitations of this are that it is only appropriate for a very specific cohort of patients.
Amniotic Membrane
Amniotic membrane (AM) has been used in ocular surface surgery for a number of years owing to its ability to provide mechanical protection to the surface epithelium as well as its natural antiinflammatory and antifibrotic properties. [18] In this way, it can act as a substrate to help the remaining epithelial cells to repopulate the corneal surface either on top of the AM, incorporating the AM into the stromal tissue, or under the AM that acts as a bandage. More recently, however, when LSCD causes a complete loss of LSCs AM has been used to expand LSC either ex vivo or in vivo. Cultivated limbal epithelial transplantation (CLET) using AM as a substrate to expand LSC in culture from small limbal explants from the other eye of the patient or from allogenic eyes. [19] This is a two-step process where a limbal explant is harvested from the undamaged eye. The LSCs are either removed from the explant and reseeded on AM from a cell suspension or explants are placed onto the AM and the LSC encouraged to expand out of their limbal niche. In both cases, once a good monolayer of cells has grown on the AM this is then transplanted onto the damaged corneal surface in a second procedure. Several studies have reported clinical success rates of CLET between 45% and 100%. The problems with this technique are the relative expense of the facilities needed to expand the LSC in culture. An alternative approach was developed called simple limbal epithelial transplantation (SLET) in which the limbal explants from the undamaged eye are transplanted onto the damaged cornea in a single procedure. [20] In this procedure the damaged cornea is prepared by removal of the pannus, the scar tissue covering the cornea, and then an AM is attached to the corneal surface with fibrin glue. The limbal explants from the fellow eye are cut into very small pieces and placed on the AM distributed across the surface. Their adherence can be encouraged by applying fibrin glue over each fragment. The entire surface is then protected either with a bandage contact lens or another layer of AM. In this way, the LSC migrates directly onto the AM to repopulate the corneal epithelium without the need for ex vivo expansion. The clinical outcomes of SLET have been shown to be similar to CLET although further trials are needed. [21] These are very encouraging clinical opportunities but it is important to understand the visual outcome of these procedures. Initially, the patient has a very sore eye with very limited vision. After LSC transplantation the eye is comfortable and the reestablished limbal region inhibits further overgrowth of the conjunctiva but the vision is often still quite poor. In the majority of cases, these still require a corneal transplant to restore vision but these will have an improved chance of success as the limbal stem cells maintain the repair of the epithelial surface.
Amniotic membrane has poor mechanical properties for handling and may degrade too rapidly to support the transplanted cells. The possibility of cross-linking it using carbodiimide chemistry is reported to increase the mechanical properties while maintaining its cell-binding capabilities and reducing its degradation. [22] An alternative strategy has involved developing a composite scaffold made of a double layer of amniotic membrane glued together with fibrin which had increased mechanical properties and performed well in a rabbit ocular reconstruction model. [23] An alternative natural tissue that has been investigated is decellularized pig corneas. The advantage of this approach is clearly that the microstructure of the substrate recreates that of the natural cornea and provides the cells with the appropriate tissue architecture and topographical cues without the immune response related to the allogenic cells. The use of decellularized tissue has been successfully used in other transplant tissue applications. Having produced the decellularized cornea there is then a choice of which cells to use to repopulate the construct for transplantation onto the injured cornea to promote the repair. [24, 25] For example, human embryonic stem cells have been differentiated into LSC-like cells and used to repopulate acellular pig corneal matrix and following transplantation in a rabbit LSCD model was able to reconstruct the surface of the cornea and maintain the cornea/conjunctiva boundary. [26] Epithelial cells have also been isolated from human AM and seeded into decellularized pig cornea and shown to stratify after 7 d. When transplanted into a rabbit model it was found to integrate well into the host tissue and maintain corneal clarity. [24] 
Collagen
The step to using collagen to build a scaffold is clearly a logical one in particular to overcome the inherent variability in tissue samples such as amniotic membrane. The mechanical properties and transparency of these scaffolds, however, need to be enhanced. The use of compressed collagen, using the Real Architecture for 3D Tissue (RAFT) technology, to build a scaffold for limbal stem cells transplantation has been studied for several years. [27, 28] The compression increases the mechanical properties of the collagen substrate and the thickness of the RAFT can be tailored to optimize transparency. [29] The best results in terms of the structure of the new epithelium were obtained when stromal fibroblasts are incorporated into the bulk of the collagen scaffold. The RAFT technology is ideal to promote this approach and it has been demonstrated that the fibroblasts can be added to the collagen solution prior to compression and are not damaged by the compression process. [30] The limbal epithelial cells were then seeded on top of the scaffold and formed a well-organized layer (Figure 3) .
Other Natural Polymers: Silks and Keratin
As another alternative to AM other natural polymers, such as silks, keratin, and chitosan, have been studied. It is important to remember, however, that for these materials considerable processing is required before use. Keratin films have been produced from hair samples and have been demonstrated to form transparent films with mechanical properties similar to AM. [31] These films have been shown to support the attachment and proliferation of corneal epithelial cells [32] and demonstrated good biocompatibility when implanted into the stroma of rabbits. [33] Silks, most often from the Bombyx mori silkworm cocoon, have been widely studied for tissue engineering applications. The advantages of this material is that the silk fibroin is mainly composed of the amino acids glycine, serine, and alanine and is thus easily functionalized with specific bioactive molecules to aid cell attachment. The fibroin, however, is coated with sericin, a glue-like protein, that is removed as the first step in the processing procedure. This leaves a fibrous material that can be dissolved and then processed into many forms including transparent films with mechanical properties and degradation behavior that can be tailored for the specific application. [34] Corneal epithelial cells have been shown to attach and grow on fibroin films in vitro but that the presence of serum is essential and for primary cells a feeder-cell layer may be required suggesting that specific cell adhesive molecules may be required to aid cell attachment to the surface. An alternative use of silk fibroin has been as a reinforcing element in collagen-based membranes. [35] This has potential to take advantage of the increased cell interaction with the collagen component and the increased mechanical properties of the fibroin component.
Synthetic Polymers
To overcome the inherent variability of biological tissues and materials, the use of synthetic polymer scaffold in which the properties can be more closely controlled during manufacture has been investigated. Several polymer scaffolds have been reported for expansion of limbal stem cells in culture and transfer to the ocular surface to enhance reepithelialization. Electropun poly(lactide-co-glycolide) (PLGA) scaffolds have been developed and demonstrated the ability to support good limbal epithelial stem cell expansion on the mats. [36, 37] The scaffolds were designed with the inclusion of micropockets to hold LSC explants (Figure 4 ) and shown to aid in the migration of the cells from the explants and allow them to transfer readily onto cornea in an ex vivo model. Using ex vivo models these have proved an effective way to transfer the cells to the epithelial surface as they migrate off the PLGA as it degrades and repopulate the corneal surface. Other degradable polyesters produced in nanofibrous form, such as poly(3-hydroxybutyrate-co-3-hydroxyvalerate), have also been reported to support the growth of a monolayer of LSC with the appropriate phenotypic morphology in in vitro studies with the potential to be used as a cell carrier sheet. [38] An alternative approach has been to expand LSC in vitro on a contact lens materials and use this to transfer the cultured epithelial cells to the wounded corneal surface. [39] Common contact lens materials are silicone hydrogels which do not support good cell attachment and growth so surface modification is required to achieve the LSC culture. An effective way to do this is using plasma polymerization and, specifically, to incorporate a carboxylic acid functionalized surface, an acrylic acid plasma polymerized surface was used. It is important in this application to achieve good cell attachment and growth on the surface but that the attachment should not be too strong so that the cells will transfer off the substrate onto the wound bed. Surface modification using plasma technologies allows the tailoring of the surface functionality to optimize the compromise between good cell expansion on the substrate and good cell transfer from the substrate.
There may also be opportunities to use more biostable synthetic polymers to support the reconstruction of the corneal epithelium. Synthetic hydrogels that can promote the diffusion of biomolecules through the water phase of the bulk material and whose mechanical properties can be tailored to mimic that of the cornea could have potential in this application. Optimizing the surface functionality of these materials may be necessary since their hydrophilic nature can render them nonfouling and thus unable to support cell attachment. Although studies have demonstrated that preadsorption of protein and peptides can improve cell attachment it has also been reported that surface functionalization with amine groups can support primary limbal epithelial cell growth without the need for additional proteins. In this study, it was demonstrated that both the water content of the hydrogel and the chain length of the surface amine functional groups was key to optimizing the limbal epithelial cell response. [40] A synthetic peptide hydrogel can be synthesized from poly (ε-lysine) cross-linked with dicarboxylic acids. The properties of this hydrogel, in terms of stiffness, water content, transparency, and amine functionality, can be controlled by the density of the poly(ε-lysine), the choice of diacid cross-linker, and the crosslink density. A cast film with a composition of 0.13 g mL −1 of poly(ε-lysine) 60% cross-linked with octanedioic acid supported a monolayer of human corneal epithelial cells (HCE-T) for 10 d and primary porcine corneal epithelial cells from explant cultures after 7 d (Figure 5 ).
Stroma
Corneal transplants are also needed in cases without LSCD. An example of this is a condition called keratoconus. Keratoconus is a progressive condition, affecting young and working age people, in which the cornea becomes misshapen significantly disrupting the refraction of light into the eye. Keratoconus is a lifelong condition and a significant health burden in workage adults, and it is the leading cause of corneal transplantation in the UK. In these patients it is the corneal stroma, which is predominantly collagen that needs replacing. These substrates require greater structural integrity than those purely for epithelial reconstruction. It has been shown that the mechanical properties of human recombinant collagen scaffold can be increased by cross-linking the collagen using carbodiimide chemistry. [41] Cross-linking also reduces degradation by collagenases enhancing the long-term stability of the transplants. These scaffolds have been used as acellular stromal implants, and have been shown to promote ingrowth of stromal cells and the growth of epithelial cells over their surface. In a 4 year follow up of ten patients using this technique for partial thickness grafts it is reported that these implants have integrated and are stable (Figure 6) . [42] More recently, a modification to these scaffolds has incorporated synthetic phospholipids to inhibit neovascularization for application in more complex corneal disorders. [43] Collagen type 1 (equine) has also been crosslinked using riboflavin and ultraviolet A (UVA), similar to the clinical treatment for keratoconus, and this has been shown to reduce the degradation of the collagen in vitro and after implantation intrastromally in rabbits. [44] Comparison of the cross-linked implants with untreated ones demonstrated that keratocytes invaded the untreated ones and laid down new collagen whereas in the cross-linked samples the keratocytes were observed on the surface of the implant only. 
Endothelium
Another clinical problem with the cornea involves the dysfunction of the endothelium. In the healthy eye, the endothelial cells form a close packed monolayer and their primary function is to pump water out of the cornea to maintain the correct level of hydration and thus transparency. In conditions such as Fuchs' endothelial dystrophy you can get loss of the endothelial cells that have low proliferation potential in vivo and when the loss reaches a critical low level they are ineffective at pumping out the fluid and the cornea swells losing its transparency. These patients are currently treated with a corneal transplant, most often using a lamella transplant procedure in which the endothelial monolayer on its Descemet's membrane, with or without a thin layer of stroma, is transplanted. There would be a significant advantage to be able to expand corneal endothelial Adv. Healthcare Mater. 2018, 7, 1701328 Figure 6 . Anterior segment optical coherence tomography images of the same central cornea, followed over 4 years in biosynthetic and human donor implanted corneas. Left column: Biosynthetic implant in a 30 year old female appears stable over time (slight differences are due to slightly different location of sections). Center column: Human donor cornea in a 52 year old male exhibits wound compression due to the sutures, posterior donorrecipient edges mismatch, posterior graft protrusion (arrowhead), and stromal compression lines (arrows) that resolve after suture removal at 1 year. Right column: Appearance of four healthy corneas aged 16-64 years. Reproduced with permission. [42] Copyright 2014, Elsevier. cells in culture on a substrate so that one donor cornea could be used to treat more than one patient. Furthermore, optimization of the substrate properties could enhance the clinical handling of the transplanted material. Compressed Type 1 collagen using the RAFT technology, as described above, has been investigated as a potential substrate for the expansion and delivery of corneal endothelial cells. [45] It was demonstrated that the mechanical properties of the samples were sufficient to be clinically manipulated into an eye using the standard transplant instruments. Furthermore, primary human corneal endothelial cells were demonstrated to attach and grow as a monolayer on the RAFT substrates and showed evidence of tight junctions and functional behavior after only 4 d of culture while maintaining their endothelial phenotypic morphology in longer term cultures. An alternative way to increase the mechanical properties to enhance clinical handling involves cross-linking of collagen-like materials. For example, gelatin solutions have been modified with methacrylic anhydride and then cross-linked using UV with and without a prior freezing step. [46] This produced a sheet that had sufficient properties for implantation into the anterior chamber of the eye. These substrates demonstrated good corneal endothelial cell attachment and growth.
Silk fibroin, as discussed above, has also been investigated as a potential substrate in corneal endothelial transplantation procedures more recently. [47] In these studies, it has been shown that the sericin component that is usually removed owing to suggestions that it can cause adverse immune responses can enhance the initial attachment of rabbit corneal endothelial cells and did not significantly change their proliferation. It is reported that the cells produced functional monolayers on silk fibroin substrates with both high and low levels of sericin that were similar to those on tissue culture polystyrene. Interestingly, silk fibroin which has been treated to remove the sericin completely has been evaluated in a rabbit model of endothelial dysfunction. The study demonstrated good support for the growth of human and rabbit corneal endothelial cells with the appropriate morphology and in vivo functionality after surgical implantation. [48] A fully synthetic hydrogel based on poly(ethylene glycol) and poly(caprolactone) (PCL) that are cross-linked with sebacic acid (Figure 7) has been studied as a substrate for corneal endothelial cell transplantation. [49] It has been shown to support excellent primary sheep corneal endothelial cell growth and monolayer formation with functional behavior after 7 d. Films of 50 µm thickness could be produced which had sufficient mechanical properties for surgical implantation into sheep eyes and this preliminary in vivo study demonstrated no adverse inflammatory response to the films with or without cells after 28 d. A similar in vitro response has been observed using a synthetic peptide based on poly(ε-lysine) cross-linked with nonanedioic acid with primary pig corneal endothelial cells (Figure 8) .
Adv. Healthcare Mater. 2018, 7, 1701328 Figure 7. Synthesis of cross-linked PHF via reaction of GE, SebCl, and α,ω-dihydroxy-PCL. [49] 
Conjunctiva Damage and Repair
When there is injury or disease to the cornea there is often damage to the conjunctiva as well. The conjunctival epithelium is a stratified epithelium consisting of epithelial cells and goblet cells. The goblet cells secrete mucins and these stabilize the tear film. A healthy conjunctiva and tear film is essential in maintaining the homeostasis of the ocular surface and this is particularly important to the success of corneal transplant surgery. Diseases and injury can cause severe scarring of the conjunctiva and these can lead to anatomical and functional impairment. There have been several studies into ways of repairing the conjunctiva and many of these are using very similar approaches to those already discussed for the corneal epithelium, although fewer of these have progressed so far. The substrate used clinically most often is amniotic membrane with or without the addition of ex vivo expanded conjunctival epithelium. It has been shown to aid reepithelialization and reduce inflammation and scarring. [50] The more complex nature of the conjunctival epithelium than the corneal epithelium adds extra considerations when designing a substrate to facilitate its expansion for transplantation. The substrate needs to support both epithelial cells and goblet cell growth and promote the secretion of mucins from the goblet cells. Several studies have suggested that during expansion of conjunctival epithelium in vitro that it is difficult to maintain the growth of the goblet cells. The question is whether there are specific cues in the basement membrane of the conjunctiva that promote the attachment of epithelial cells and goblet cells and whether these can be recreated in a transplant substrate. One way to do this could be to use decellularized conjunctiva as the substrate. We demonstrated that human conjunctiva explant cultures repopulated the decellularized conjunctiva and that there was some MUC5AC staining demonstrating the presence of goblet cells. [51] However, this was very difficult to handle surgically. Another approach that is taken when there is very severe scarring is to insert a expanded poly(tetrafluoroethylene) (ePTFE) surgical membrane to separate the scar tissues and allow the movement between the lid and the eye. [52] We investigated if it would be possible to culture conjunctival epithelium on to this membrane. To be able to do this it is necessary to modify the surface of the ePTFE to overcome its hydrophobicity using an ammonia gas plasma. [53] This renders the surface hydrophilic without influencing the structural or mechanical properties. We found that we could get good cell growth of primary conjunctival cells on the plasmatreated ePTFE by 14 d and that about 15% of the cells stained positive for MUC5AC although after longer time periods in vitro the total cell number reduced. [54] Plastic compressed collagen, as discussed above for the cornea, has been evaluated in vitro as a substrate for expansion of human conjunctival epithelial cells and is reported to promote good attachment and growth of a monolayer for conjunctival epithelial cells and importantly a population of cells that stained positively for the putative stem cells markers. [55] An alternative collagen-based scaffold uses a vitrification process to enhance the mechanical properties for this application. [56] This process produces a collagen scaffold with densely packed, randomly orientated fibers that closely mimics those in the conjunctival stroma and produced a substrate that is mechanically strong and elastic. It has been shown to support the growth of primary rabbit conjunctival epithelial and goblet cells with the secretion of mucins. Furthermore, transplantation of the vitrified collagen membranes with attached cultured cells into a rabbit conjunctival epithelial defect model demonstrated better reepithelialization with incorporated goblet cells than membranes without cells or the negative control group where the conjunctival wound was untreated.
There could be an argument to design an in vitro culture system that specifically promotes the expansion of goblet cells, rather than a balanced epithelium with both epithelial and goblet cells, for transplantation to ensure sufficient goblet cells postsurgery. Human conjunctiva explants were cultured on a range of substrates including recombinant human collagen, Bombyx mori silk, degradable polyesters, poly(acrylic acid), poly(vinyl alcohol), and poly(ethylene terephthalate), in specific goblet cell culture media. [57] It was reported that there was cell outgrowth on all substrates but those on poly(caprolactone) had a high percentage that were dead. Using a putative goblet cell marker, cytokeratin-7, it is reported that most of the attached cells were goblet cells. Unfortunately, the functionality of these cells was not evaluated by staining for mucin production, for example, MUC5AC. A lot more work needed, therefore, to establish if goblet cells produced in this way are useful in the transplant strategy.
In recent discussions with our clinical colleagues they were very interested in the mechanical properties of our poly (ε-lysine) gels discussed above for this application so we have recently seeded a conjunctival cell line, HCjE-Gi cells, onto these and demonstrated that they support good monolayer growth and that with airlifting this layer will stratify. After 14 d in culture we demonstrated distributed staining of MUC5AC suggesting that mucin has been secreted. There is a lot more work that needs to be done to optimize this approach and determine how they perform in vivo.
Trabecular Meshwork Damage and Repair
There is a question concerning whether regenerative medicine could have a role in the restructuring of the trabecular meshwork. The trabecular meshwork is very important in controlling the outflow of fluid from the eye. Aqueous humor is produced by the ciliary processes and it flows through the pupil to the anterior chamber where it provides nutrients to the cornea. The majority then flows out of the eye through the trabecular meshwork to the Schlemm's canal where it drains into the vascular system. The trabecular meshwork has a sieve-like structure that controls the flow rate to maintain the intraocular pressure. It is widely reported that the build-up of intraocular pressure that is associated with glaucoma is due to failure of the trabecular meshwork leading to a decrease in the outflow of aqueous humor. It is thought that changes in the trabecular meshwork occur that include increased stiffness of the tissue, loss of trabecular meshwork cells, increased deposition of extracellular matrix by the remaining cells, and cytoskeletal reorganization in the cells. Currently, the most up to date surgical treatment for glaucoma related to this cause is to create a drainage channel through the blocked tissue; however, there is evidence that there are trabecular meshwork progenitor cells at the inner surface of the limbus and that these might be able to be used to repopulate the trabecular meshwork. [11] So, the question arises whether it would be useful to have a scaffold on which to grow these cells to reintroduce them to the trabecular meshwork?
The use of collagen to build a 3D in vitro model of the trabecular meshwork for testing drugs to treat glaucoma has been reported. [58] In this study, they produced the porous aligned collagen scaffolds using a unidirectional freezing procedure followed by lyophilization and cross-linking (Figure 9) . In some samples chondroitin sulfate was also added. They showed that primary pig trabecular meshwork cells grew well on both the scaffolds and began to migrate into the scaffolds over the 2 week culture period. For this application, the porosity of the scaffold and its mechanical properties will be very important so that the cells function correctly. Photolithography has been used to create an in vitro scaffold for human trabecular meshwork cells with features that are 7 µm wide, about 5 µm high, and 12 µm apart out of SU-8 2010 photoresist to mimic the outflow environment in vivo. [59] These were coated with gelatin and seeded with human trabecular meshwork cells, which after culturing for 14 d formed a 40 µm thick trabecular meshwork structure. This was demonstrated to behave as expected in response to steroids and therefore could act as a useful in vitro 3D model for glaucoma drug development. Although the mechanical properties of this scaffold are unlike tissue this study suggests that the structural features could be capable of driving ex vivo growth of tissue-like structures.
Outflow of aqueous from the eye passes from the trabecular meshwork into the Schlemm's canal. Resistance to the outflow can be influenced by the endothelial cell layer that lines the inner wall of the Schlemm's canal. [60] It is known that 2D in vitro growth of Schlemm's canal endothelial cells results in dedifferentiation; however, growth of these cells on 3D substrates similar to those above created using photolithography has been investigated. In these studies, gelatin coating was not useful but a coating with a hyaluronic acid gel allowed the growth of 3D cultures that maintained many of their in vivo characteristics. [61] These studies demonstrate the potential to build structures in vitro that promote these specialized cells to behave in a way that mimics their in vivo behavior. Other biomaterial scaffolds may be more appropriate for in vivo replacement strategies and ultimately a system in which a coculture of Schlemm's canal endothelial cells with trabecular meshwork cells may lead to new regenerative medicine approaches for the treatment of glaucoma.
Conclusion
The ocular application of regenerative medicine and tissue engineering is one area where there has been some successful translation down the clinical pathway. There is still slow progress, however, in the clinical use of synthetic biomaterials although the laboratory research demonstrates advantages over the biological tissues and materials currently used. There is a real clinical need for this development where biological tissues are not available. There may be opportunities to target the ocular surface reconstruction as an area where significant progress in clinical translation of these technologies can be successful. This could lead to new therapies for ocular surface vision loss but also for the development of the biomaterials innovations in other areas of regenerative medicine and tissue engineering. On the pathway to the clinical outcome these technologies also lend themselves very effectively to the design of in vitro models of the ocular surface which could have a significant benefit in understanding wound healing and the development of new drugs and therapies. [58] 
